Actovegin 40 mg/ml: A Metabolic Cytoprotector for Cellular Recovery Under Ischemia and Hypoxia

Every cell in the human body is a miniature power plant, its mitochondria continuously converting glucose and oxygen into ATP molecules. When blood flow is disrupted and oxygen delivery drops, this energy assembly line grinds to a halt, triggering a cascade of irreversible damage. Actovegin 40 mg/ml is a deproteinized hemoderivative of calf blood containing a broad spectrum of low-molecular-weight biologically active compounds: amino acids, oligopeptides, nucleosides, glycolipids, and trace elements. It is supplied as a sterile injectable solution (5 ml per ampoule, 5 ampoules per pack). The drug acts as a metabolic cytoprotector, enhancing cellular resilience to oxygen deprivation and accelerating glucose utilization independently of insulin signaling.

🔬 Mechanism of Action: Insulin-Like Metabolic Activation

Actovegin is neither a hormone, nor a neurotransmitter, nor a classical vasodilator. Its uniqueness resides in its capacity to directly intervene in the metabolism of a hypoxia-stricken cell and to shift its energy production toward the more efficient aerobic pathway:

1. Insulin-Like Stimulation of Glucose Transport.

Actovegin's components activate GLUT1 and GLUT4 transporters, ensuring the influx of glucose into the cell even under conditions of insulin resistance. This is critically important for neurons, which cannot store glucose and are entirely dependent on its continuous delivery from the bloodstream.

2. Enhancement of Oxygen Utilization.

The drug increases the activity of Krebs cycle enzymes (pyruvate dehydrogenase, citrate synthase) and mitochondrial respiratory chain enzymes (cytochrome c oxidase), thereby raising the efficiency of oxidative phosphorylation. The cell begins to extract more energy from the same quantity of substrate.

3. Antioxidant Defense.

Actovegin upregulates the activity of superoxide dismutase — the key enzyme that neutralizes the superoxide radical — and reduces the intensity of lipid peroxidation within cell membranes.

4. Acceleration of Repair and Angiogenesis.

The drug stimulates collagen synthesis and the proliferation of fibroblasts and endothelial cells, thereby accelerating the healing of wounds and ulcers and promoting the restoration of the microcirculatory bed.

📋 Clinical Indications

Actovegin is deployed in neurology, angiology, endocrinology, surgery, and dermatology:

1. Neurological Disorders:

• Ischemic and hemorrhagic stroke (recovery phase).
• Chronic cerebral ischemia, dyscirculatory encephalopathy.
• Traumatic brain injury and its sequelae.
• Diabetic polyneuropathy.
• Cognitive impairments of vascular and degenerative origin.

2. Vascular Pathology:

• Obliterative atherosclerosis of the lower limb arteries.
• Chronic venous insufficiency with trophic disturbances.
• Angiopathy (diabetic, hypertensive).

3. Surgery, Dermatology, Combustiology:

• Trophic ulcers (venous, arterial, diabetic).
• Pressure sores.
• Burns and frostbite.
• Long-standing non-healing wounds.
• Radiation-induced skin and mucosal lesions.

4. Ophthalmology:

• Ischemic optic neuropathy.
• Diabetic retinopathy.
• Corneal burns and injuries.

💉 Administration and Dosing Regimen

Actovegin 40 mg/ml is a clear, yellowish solution.

• Route of Administration: Intramuscular, intravenous (slow bolus or drip infusion), or intra-arterial. The specific route depends on the severity of the condition and is determined by the physician.
• Dosing Regimen depends on the pathology:
  • Cerebrovascular and metabolic disorders: 10–20 ml (400–800 mg) IV drip daily for 10–14 days, followed by 5–10 ml (200–400 mg) IM for 14–20 days.
  • Diabetic polyneuropathy: 10–20 ml (400–800 mg) IV drip daily for 14–20 days.
  • Wound and ulcer healing: 10 ml (400 mg) IV or 5 ml (200 mg) IM daily.
• Infusion Rate: IV drip — not exceeding 2 ml/min.

⚠️ Contraindications and Precautionary Measures

Actovegin is not prescribed in the setting of:

• Individual hypersensitivity to the drug's components.
• Decompensated heart failure.
• Oliguria, anuria, pulmonary edema.
• Fluid retention in the body.
• Pregnancy and breastfeeding (with caution, under strict indications).

Precautionary Measures:

• Prior to the first injection, a test dose (2 ml IM) is recommended due to the risk of anaphylactic reactions.
• With IM administration, the volume of a single injection must not exceed 5 ml.
• Infusion solutions are prepared using 0.9% NaCl or 5% glucose.

📊 Tolerability Profile

Actovegin is generally well tolerated. In rare instances, the following may occur:

• Allergic reactions (urticaria, skin rash, pruritus, skin hyperemia, anaphylactic shock).
• Dyspeptic symptoms (nausea).
• Headache, weakness.
• Pain, burning sensation, and swelling at the IM injection site.

📦 Storage Conditions

Ampoules must be stored in a light-protected location at room temperature (not exceeding 25 °C / 77 °F). Do not freeze. Keep out of the reach of children.

📦Find out about the delivery to your country on WhatsApp